Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
XenoGesis
XenoGesis
Activities:
Research & Development
X
LinkedIn
Trending Articles
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
How advanced technologies are unlocking the future of drug manufacturing
As the drug production landscape changes, it opens the door to pursue hybrid opportunities that push the boundaries of technological advancement in the field, reports Jon...
Andelyn Biosciences and Grace Science, LLC partner to manufacture AAV gene therapy
The partnership will seek to maximise programme efficiency, support the ongoing clinical trial and accelerate this critical therapy to patients
Teva UK and Closed Loop Medicine partner to advance personalised medicine development
SaMD platform aims to advance personalised medicine development, improve drug efficacy and patient outcomes with specific chronic conditions
Henkel facilities receive EXCiPACT certificate as suppliers of pharmaceutical excipients
The certification means Henkel meets EXCiPACT’s guidelines for good manufacturing practice (GMP) and good distribution practice (GDP)
Upcoming event
BioProcess International Europe
9-12 April 2024 | Exhibition | RAI Amsterdam
See all
Related Content
Drug Delivery
Quay Pharma partners with XenoGesis on drug development
The partnership aims to accelerate the drug development process for both companies’ clients
Research & Development
Contract research organisation XenoGesis expands services
Nottingham, UK-based firm adds CYP induction and gene expression assay services to portfolio
Research & Development
XenoGesis aims to expand into US market
Appoints Sabrina Mogle as a business development specialist to spearhead growth in the region
Research & Development
XenoGesis strengthens DMPK team with appointment of Peter White
He specialises in mass spectrometry and bioanalysis
Research & Development
XenoGesis invests in new cutting-edge technology
Will allow the DMPK and bioanalysis specialist to increase capacity and add new capabilities
Research & Development
XenoGesis appoints Director of External Projects
Graham Trevitt joins the Nottingham, UK-based contract research organisation
Research & Development
UK companies Molecular Profiles and XenoGesis forge partnership
Nottingham-based companies will support drug developers during pre-clinical and formulation stages
Subscribe now